KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesDepreciation & Amortization (CF)DivestmentsExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cardlytics (CDLX) Change in Cash (2017 - 2025)

Historic Change in Cash for Cardlytics (CDLX) over the last 9 years, with Q3 2025 value amounting to -$2.8 million.

  • Cardlytics' Change in Cash rose 3464.79% to -$2.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$23.0 million, marking a year-over-year increase of 53.99%. This contributed to the annual value of -$26.2 million for FY2024, which is 1299.62% up from last year.
  • Cardlytics' Change in Cash amounted to -$2.8 million in Q3 2025, which was up 3464.79% from -$5.3 million recorded in Q2 2025.
  • In the past 5 years, Cardlytics' Change in Cash ranged from a high of $320.3 million in Q1 2021 and a low of -$362.9 million during Q2 2021
  • Its 5-year average for Change in Cash is -$13.1 million, with a median of -$5.3 million in 2025.
  • Within the past 5 years, the most significant YoY rise in Cardlytics' Change in Cash was 1407513.09% (2021), while the steepest drop was 940117.8% (2021).
  • Quarter analysis of 5 years shows Cardlytics' Change in Cash stood at -$3.9 million in 2021, then tumbled by 323.76% to -$16.6 million in 2022, then surged by 110.18% to $1.7 million in 2023, then plummeted by 182.49% to -$1.4 million in 2024, then crashed by 99.71% to -$2.8 million in 2025.
  • Its last three reported values are -$2.8 million in Q3 2025, -$5.3 million for Q2 2025, and -$13.5 million during Q1 2025.